Loading…
Vitamin E, D-Calpan and biotin prices remain under downward pressure, although declines have slowed; vitamin C has firmed while several other markets are stable. Q4 coverage is largely secured, with Q1 coverage varying by product.
Ample supply weighs on some vitamin prices, while restricted offers and allocations are slowing declines in others. The mixed conditions point to limited near-term price movement overall.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.